The European Medicine Agency (EMA) on Wednesday, warned that anti-malaria drugs, chloroquine and hydroxychloroquine, should only be used to treat COVID-19 in clinical trials or in case of “national emergency”.
The European Medicine Agency (EMA) on Wednesday, warned that anti-malaria drugs, chloroquine and hydroxychloroquine, should only be used to treat COVID-19 in clinical trials or in case of “national emergency”.